The Ph.D. program at Sri Ramachandra Institute of Higher Education and Research (SRIHER), Chennai, is a full-time research doctorate offered across a wide range of disciplines including Medicine, Dental Sciences, Pharmacy, Nursing, Physiotherapy, Biomedical Sciences, Management, Allied Health Sciences, Public Health, Engineering and Technology, and more. The minimum duration is 3 years for full-time candidates and 4 years for part-time candidates. The total fee for a full-time Ph.D. is Rs. 2,51,500 for the minimum 3-year duration. SRIHER is a Category-I Deemed University with NAAC A++ accreditation, ranked 60th overall and 21st in Medical category by NIRF 2025, with over 650 active Ph.D. scholars and 447 degrees awarded to date.
Admissions for the April 2026 session have already been processed (application deadline was January 31, 2026; entrance exam was held February 16-18, 2026; commencement April 1, 2026). The next session is expected to be October 2026. Candidates are advised to watch the official website sriramachandra.edu/admissions/ph-d-admission/ for the October 2026 session notification, which is typically released 2-3 months before the session start.
Key Points
- Ph.D. is offered in over 15 faculties/disciplines, making SRIHER one of the most comprehensive research universities in South India for health sciences and allied fields.
- The Founder-Chancellor Shri N.P.V. Ramasamy Udayar Research Fellowship provides stipend support to eligible full-time scholars selected through the SRIHER entrance exam.
- Candidates holding UGC-NET (JRF) qualification are exempted from the entrance examination and are directly called for interview.
- An Integrated MD/MS-Ph.D. program (ICMR-sponsored) is available for medical postgraduates, with a minimum duration of 5 years.
- SRIHER has a GLP-accredited pre-clinical toxicology facility, FDA-audited Clinical Trial Division, and a BIRAC-supported Bio-Nest incubator, providing world-class research infrastructure.
- The university has active research collaborations and MoUs with institutions in the USA, Europe, and Australia, and receives funding from DST, DBT, ICMR, NIH (USA), Wellcome Trust, and the Bill and Melinda Gates Foundation.
Comments